The U.S. Food and Drug Administration (FDA) has approved Dupixent (dupilumab) injections as an add-on therapy for adults with chronic obstructive pulmonary disease (COPD) who continue to struggle ...
Sanofi and Regeneron’s Dupixent has already transformed the treatment ... it seems the IL-4 and IL-13 inhibitor still has more to give. At the American Academy of Dermatology (AAD) annual ...
Sanofi and Regeneron’s blockbuster biologic Dupixent (dupilumab ... to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or ...